DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisolone (Prednisolone) - Infection - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Infection (86)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include infection. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 86   Next >>

Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (4 standard cycles)

Cyclophosphamide
    Dosage: 650 mg/m2, day 1 (4 standard cycles)

Cyclophosphamide
    Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, day 1 (4 standard cycles)

Doxorubicin HCL
    Dosage: 35 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, day 1-3 (4 standard cycles)

Etoposide
    Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
    Administration route: Oral

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
    Administration route: Oral

Vincristine
    Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (4 standard cycles)



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-24

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-14

Patient:

Reactions: Transplant Failure, Cardiac Failure, Myelodysplastic Syndrome, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Carmustine
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Cytarabine
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Indication: Mantle Cell Lymphoma

Etoposide
    Indication: Mantle Cell Lymphoma

Mabthera
    Indication: Mantle Cell Lymphoma

Melphalan Hydrochloride
    Indication: Mantle Cell Lymphoma

Prednisolone
    Indication: Mantle Cell Lymphoma

Vincristine
    Indication: Mantle Cell Lymphoma



Possible Prednisolone side effects in

Reported by a physician from Denmark on 2012-08-06

Patient:

Reactions: Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Carmustine
    Dosage: on day 1; beam/c
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Dosage: day 1; cycle 5; chop regimen
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Dosage: day 1; cycle 1; chop regimen

Cyclophosphamide
    Dosage: day 2-5 in beac regimen

Cyclophosphamide
    Dosage: day 1; cycle 3; chop regimen

Cytarabine
    Dosage: 3 or 2 g/m2, four-3 hour infusions; cycle 4
    Indication: Mantle Cell Lymphoma

Cytarabine
    Dosage: 3 or 2 g/m2, four-3 hour infusions; cycle 2

Cytarabine
    Dosage: day 2-5 in beam or beac regimen

Cytarabine
    Dosage: 3 or 2 g/m2, four-3 hour infusions; cycle 6

Doxorubicin HCL
    Dosage: on day 1; cycle 3
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1; cycle 1

Doxorubicin HCL
    Dosage: on day 1; cycle 5

Etoposide
    Dosage: day 2- 5; beam/c regimen
    Indication: Mantle Cell Lymphoma

Melphalan Hydrochloride
    Dosage: on day 6; beam regimen
    Indication: Mantle Cell Lymphoma

Prednisolone
    Dosage: on day 1-5; cycle 1

Prednisolone
    Dosage: on day 1-5; cycle 3

Prednisolone
    Dosage: on day 1-5; cycle 5
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: day 1 cycle 5

Rituximab
    Dosage: day1 cycle 6, also given on day 9 for in-vivo purging

Rituximab
    Dosage: day 1 from cycle 4
    Indication: Mantle Cell Lymphoma

Vincristine
    Dosage: on day 1 ; cycle 5

Vincristine
    Dosage: on day 1; cycle 1
    Indication: Mantle Cell Lymphoma

Vincristine
    Dosage: on day 1; cycle 3



Possible Prednisolone side effects in

Reported by a physician from Japan on 2012-07-17

Patient:

Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Neupogen
    Indication: B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Rituxan
    Dosage: 6 doses-2 days prior to each cycle of chop
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Prednisolone side effects in

Reported by a physician from United Kingdom on 2012-07-17

Patient:

Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-07-13

Patient: female

Reactions: Gastrointestinal Haemorrhage, Trigeminal Neuralgia, RED Blood Cell Abnormality, Disseminated Intravascular Coagulation, Pyrexia, Circulatory Collapse, Staphylococcal Bacteraemia, Melaena, White Blood Cell Count Increased, Hepatitis Fulminant, Hepatosplenomegaly, Mechanical Ventilation, Alanine Aminotransferase Increased, Plasmapheresis, Anaemia, Thrombotic Thrombocytopenic Purpura, Convulsion, Haemodialysis, Haemoglobin Decreased, Renal Impairment, Oliguria, Aspartate Aminotransferase Increased, Blood Smear Test Abnormal, Transfusion, Haemorrhagic Diathesis, Platelet Count Decreased, Altered State of Consciousness, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: unk
    Start date: 2007-10-01
    End date: 2009-10-28

Tracleer
    Dosage: 62.5 mg, bid
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2008-07-10
    End date: 2009-09-30

Tracleer
    Dosage: 62.5 mg, qd
    Administration route: Oral
    Start date: 2008-07-02
    End date: 2008-07-09

Other drugs received by patient: Carbocisteine; Omeprazole; Sarpogrelate Hydrochloride; Beraprost Sodium; Meloxicam; Trimebutine Maleate



Possible Prednisolone side effects in 36 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-11

Patient: 36 year old male

Reactions: Squamous Cell Carcinoma, Graft Versus Host Disease, Pain of Skin, Nail Growth Abnormal, Bowen's Disease, Skin Papilloma, Skin Lesion, Papilloma Viral Infection, Infection

Drug(s) suspected as cause:
Cyclosporine
    Dosage: 30 mg, bid
    Indication: Bone Marrow Transplant

Prednisolone
    Dosage: 3 mg, daily
    Indication: Bone Marrow Transplant

Other drugs received by patient: Imiquimod



Possible Prednisolone side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir



Possible Prednisolone side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-05

Patient:

Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Neupogen
    Indication: B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: 6 doses-2 days prior to each cycle of chop
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Prednisolone side effects in 40 year old male

Reported by a individual with unspecified qualification from Germany on 2012-07-03

Patient: 40 year old male

Reactions: Nasopharyngitis, Colitis Ulcerative, Femoral Artery Occlusion, Lipoprotein (A) Increased, Pyrexia, Thromboangiitis Obliterans, Hyperhomocysteinaemia, TOE Amputation, Pain in Extremity, Arterial Thrombosis Limb, Foot Amputation, Hypercoagulation, Acquired Protein S Deficiency, Impaired Healing, Diarrhoea, Hyperfibrinogenaemia, Coagulation Factor Viii Level Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Octagam
    Dosage: 10 g (1x 1/d) intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2011-07-23
    End date: 2011-08-13

Prednisolone
    Dosage: 50 mg (1x 1/d) oral
    Administration route: Oral
    Indication: Diarrhoea
    Start date: 2011-08-13
    End date: 2011-09-23

Other drugs received by patient: Vancomycin; Sulfametthoxazole and Trimethoprim; Omeprazole; Mesalamine; Levofloxacin; Fluconazole



Possible Prednisolone side effects in

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-27

Patient:

Reactions: Angina Pectoris, Death, Ejection Fraction Decreased, Cardiotoxicity, Cardiovascular Disorder, Lymphoma, Myocardial Infarction, Infection

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Lymphoma

Doxorubicin HCL
    Dosage: average dose: 336,5 mg/m2 (range 50-680)
    Indication: Lymphoma

Prednisolone
    Indication: Lymphoma

Vincristine
    Indication: Lymphoma



Possible Prednisolone side effects in male

Reported by a physician from Netherlands on 2012-06-25

Patient: male, weighing 84.3 kg (185.5 pounds)

Reactions: Upper-Airway Cough Syndrome, Gastroenteritis, Pyrexia, Pneumococcal Sepsis, Cough, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aeb071
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2009-09-16

Certican
    Dosage: 0.25 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-09-07

Prednisolone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-09-07



Possible Prednisolone side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 54 year old male

Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Infection

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2, day 8
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Etoposide
    Dosage: 200 mg/m2, day1-3
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-14
    Indication: Chemotherapy

Procarbacin
    Dosage: 100 mg/m2, day 1-7

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 49 year old male

Reactions: Neutropenia, Infection

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 90 mg/m2, day1-2
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-5
    Indication: Chemotherapy

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 67 year old male

Reactions: Neutropenia, Infection

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 90 mg/m2, day1-2
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-5
    Indication: Chemotherapy

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 30 year old female

Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Peritonitis, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-5
    Indication: Chemotherapy

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in female

Reported by a physician from United Kingdom on 2012-06-15

Patient: female, weighing 46.3 kg (101.9 pounds)

Reactions: Diarrhoea, Bronchopneumonia, Neutropenic Sepsis, Lower Extremity Mass, Oxygen Saturation Decreased, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1150 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Doxorubicin HCL
    Dosage: 75 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Mabcampath
    Dosage: 30 mg, once on day 1 and 3
    Indication: T-Cell Lymphoma
    Start date: 2011-12-07
    End date: 2012-03-22

Prednisolone
    Dosage: 100 mg, day 1-5
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Vincristine Sulfate
    Dosage: 2 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Other drugs received by patient: Levothyroxine Sodium; Lansoprazole; Lenograstim; Cotrim; Ondansetron; Domperidone; Valganciclovir; Enoxaparin



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-14

Patient: 49 year old male

Reactions: Off Label Use, Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate

Cyclophosphamide

Doxorubicin HCL

Etoposide

Prednisolone
    Administration route: Oral

Procarbazine Hydrochloride
    Administration route: Oral

Vincristine



Possible Prednisolone side effects in 67 year old male

Reported by a physician from Germany on 2012-06-11

Patient: 67 year old male

Reactions: Post Transplant Lymphoproliferative Disorder, Plasmablastic Lymphoma, Neutropenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bendamustine

Bendamustine
    Indication: Plasmablastic Lymphoma

Bendamustine
    Dosage: part of r-chop chemotherapy; later received with bendamustine

Cyclophosphamide
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Cyclosporine
    Dosage: 200 milligram;
    Indication: Immunosuppressant Drug Therapy

Doxorubicin HCL
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Prednisolone
    Dosage: 5 milligram;
    Indication: Immunosuppressant Drug Therapy

Prednisone TAB
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Rituximab
    Dosage: part of r-chop chemotherapy; later received with bendamustine

Rituximab

Rituximab
    Dosage: 2 cycles; followed by r-chop
    Indication: Plasmablastic Lymphoma

Vincristine
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Other drugs received by patient: Immune Globulin NOS



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-06-11

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on d8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650mg/m2 standard cycles 1250 for the escalated cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 35mg/m2,on d1 for escalated cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100mg/m2 for the standard cycles d1 to 3; 200mg/m2 for the escalated cycles from d1-3 iv
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on days 1 to 14 in every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day1-7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on d8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-08

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (4 standard cycles)

Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650 mg/m2, day 1 (4 standard cycles)

Doxorubicin HCL
    Dosage: 35 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, day 1 (4 standard cycles)

Etoposide
    Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, day 1-3 (4 standard cycles)

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
    Administration route: Oral

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
    Administration route: Oral

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (4 standard cycles)



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Germany on 2012-06-08

Patient: 49 year old male

Reactions: Post Transplant Lymphoproliferative Disorder, Plasmablastic Lymphoma, Neutropenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Cyclosporine
    Dosage: 325 milligram;
    Indication: Immunosuppressant Drug Therapy

Doxorubicin HCL
    Dosage: on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Prednisolone
    Dosage: 100mg, d1-5 of 22d cycle; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Vincristine
    Dosage: (max 2mg) on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma



Possible Prednisolone side effects in 84 year old female

Reported by a physician from Japan on 2012-06-08

Patient: 84 year old female, weighing 35.0 kg (77.0 pounds)

Reactions: Respiratory Failure, Cerebral Haemorrhage, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Aspirin
    Administration route: Oral
    Indication: Cardiac Valve Disease
    End date: 2012-04-13

Concentrated RED Cells
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-13
    End date: 2012-04-13

Galantamine Hydrobromide
    Administration route: Oral
    Indication: Dementia Alzheimer's Type
    Start date: 2012-02-17
    End date: 2012-04-05

Galantamine Hydrobromide
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-04-13

Lendormin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Prednisolone
    Administration route: Oral
    Indication: Lupus Nephritis
    End date: 2012-04-13

Warfarin Sodium
    Administration route: Oral
    Indication: Cardiac Valve Disease
    End date: 2012-04-13

Other drugs received by patient: Lasix; Alendronate Sodium; Cotrim; Onealfa; Gasmotin; Rabeprazole Sodium; Strocain



Possible Prednisolone side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06

Patient: 76 year old male

Reactions: Malaise, Pyrexia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Chlorambucil (Chlorambucil) (Tablet)
    Dosage: 18 milligram (1-2) (1000 milligram (18 milligram, 1 in 1 days), oralq
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-03-23

Ofatumumab (Ofatumumab)
    Dosage: 1000 milligram), intravenous
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-03-21

Prednisolone
    Dosage: 20 milligram (20 milligram, 1 in 1 days), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-23
    End date: 2012-04-25

Other drugs received by patient: Bendamustine (Bendamustine); G-CSF (G-Csf); Acetaminophen; Allopurinol; Acyclovir; Chlorpheniramine Maleate; Ranitidine Hydrochloride; Metoclopramide



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-05

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1

Doxorubicin HCL
    Dosage: for escalated cycles on day 1

Doxorubicin HCL
    Dosage: for standard cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: for the standard cycles, day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in female

Reported by a physician from United Kingdom on 2012-06-04

Patient: female, weighing 46.3 kg (101.9 pounds)

Reactions: Bronchopneumonia, Oxygen Supplementation, Lymphoma, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1150 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Doxorubicin HCL
    Dosage: 75 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Mabcampath
    Dosage: 30 mg, once on day 1 and 3
    Indication: T-Cell Lymphoma
    Start date: 2011-12-07
    End date: 2012-03-22

Prednisolone
    Dosage: 100 mg, day 1-5
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Vincristine
    Dosage: 2 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Other drugs received by patient: Levothyroxine Sodium; Lenograstim; Valganciclovir; Domperidone; Lansoprazole; Enoxaparin; Cotrim; Ondansetron



Possible Prednisolone side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-31

Patient: 76 year old male

Reactions: Malaise, Pyrexia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Leukeran
    Dosage: 18 milligram (18 milligram, 1 in 1 days) , oral
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-03-23

Ofatumumab (Ofatumumab)(unknown)
    Dosage: (1000 milligram) intravenous (not otherwise specified)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-03-22

Prednisolone
    Dosage: 20 milligram (20 milligram,l 1in 1 days) , oral
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-04-25

Other drugs received by patient: Chlorpheniramine (Chlorpheniramine)(unknown); Ranitidine; Allopurinol; Bendamustine (Bendamustine)(unknown); Acetaminophen; Metoclopramide; Aciclovir (Aciclovir)(unknown); G-CSF (G-Csf)(unknown)



Possible Prednisolone side effects in female

Reported by a physician from United Kingdom on 2012-05-29

Patient: female, weighing 46.3 kg (101.9 pounds)

Reactions: Death, Metapneumovirus Infection, Hypotension, Cytomegalovirus Infection, Oxygen Supplementation, Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1150 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Doxorubicin HCL
    Dosage: 75 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Mabcampath
    Dosage: 30 mg, once on day 1 and 3
    Indication: T-Cell Lymphoma
    Start date: 2011-12-07
    End date: 2012-03-22

Prednisolone
    Dosage: 100 mg, day 1-5
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Vincristine
    Dosage: 2 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Other drugs received by patient: Lansoprazole; Valganciclovir; Levothyroxine Sodium; Motilium; Lenograstim; Ondansetron; Enoxaparin; Cotrim



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017